CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AC4. A total of 14 filers reported holding CLOVIS ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,723 | -100.0% | 23,616,000 | 0.0% | 0.13% | -45.1% |
| Q3 2022 | $16,885,000 | 0.0% | 23,616,000 | 0.0% | 0.24% | -38.4% |
| Q2 2022 | $16,885,000 | -10.1% | 23,616,000 | -5.0% | 0.38% | -11.9% |
| Q1 2022 | $18,774,000 | +8.6% | 24,866,000 | 0.0% | 0.44% | +15.9% |
| Q4 2021 | $17,282,000 | +9.1% | 24,866,000 | +2.1% | 0.38% | -10.0% |
| Q3 2021 | $15,838,000 | -12.4% | 24,366,000 | 0.0% | 0.42% | -16.4% |
| Q2 2021 | $18,076,000 | -21.0% | 24,366,000 | -19.0% | 0.50% | -45.1% |
| Q1 2021 | $22,875,000 | -33.4% | 30,066,000 | -38.1% | 0.91% | -30.7% |
| Q4 2020 | $34,360,000 | +10.7% | 48,566,000 | +4.3% | 1.32% | -21.3% |
| Q3 2020 | $31,025,000 | +43.3% | 46,566,000 | +30.9% | 1.67% | -9.2% |
| Q2 2020 | $21,651,000 | +92.4% | 35,566,000 | +96.9% | 1.84% | +53.0% |
| Q1 2020 | $11,252,000 | -7.2% | 18,066,000 | -5.2% | 1.20% | -10.1% |
| Q4 2019 | $12,121,000 | +162.1% | 19,066,000 | +72.3% | 1.34% | +98.5% |
| Q3 2019 | $4,625,000 | -63.5% | 11,066,000 | -38.5% | 0.68% | +80.5% |
| Q4 2018 | $12,670,000 | – | 18,000,000 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Castle Creek Arbitrage, LLC | 3,000,000 | $1,874,000 | 0.49% |
| Opti Capital Management, LP | 4,500 | $2,815,000 | 0.42% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 30,000,000 | $18,578,000,000 | 0.36% |
| CAMDEN ASSET MANAGEMENT L P /CA | 17,336,000 | $10,785,000 | 0.34% |
| CSS LLC/IL | 5,850,000 | $3,650,000 | 0.21% |
| MIZUHO SECURITIES USA LLC | 4,000,000 | $2,504,000 | 0.12% |
| FARALLON CAPITAL MANAGEMENT LLC | 18,750,000 | $11,684,000 | 0.08% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 4,516,000 | $2,834,000 | 0.06% |
| AQR Arbitrage LLC | 7,350,000 | $4,609,000 | 0.05% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 8,000 | $1,562,000 | 0.04% |